正压通气装置市场规模、份额及成长分析（依产品类型、应用、最终用户及地区划分）－2026-2033年产业预测

预计到 2024 年，正压通气 (PAP) 市场规模将达到 23.9 亿美元，到 2025 年将达到 25.1 亿美元，到 2033 年将达到 37.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 5.2%。

全球正压通气（PAP）市场正经历显着成长，这主要得益于人们对睡眠呼吸中止症等睡眠相关呼吸障碍的认识和诊断水准的提高。这些疾病对整体健康有重大影响，因此对有效治疗方法的需求日益增长。 PAP设备，特别是持续性正压呼吸器（CPAP）和双水平气道正压通气（BiPAP），提供了一种非侵入性解决方案，可以改善呼吸功能并缓解症状。市场成长的驱动因素包括医疗费用支出的增加、设备技术的进步（旨在提高舒适度和功能性）以及人口老化导致患者更容易患上这些疾病。製造商、医疗保健提供者和研究机构之间的合作正在推动创新。然而，患者依从性、成本和监管因素等挑战仍需要持续改善产品、扩大分销管道并加强教育，以提高PAP疗法的接受度。

正压通气装置市场驱动因素

全球睡眠障碍发生率的不断上升是推动正压通气设备市场成长的主要因素。阻塞型睡眠呼吸中止症症等疾病需要有效的治疗方案，而正压通气机是治疗这些疾病的标准疗法。预防睡眠期间的气道阻塞对于缓解相关併发症至关重要。随着睡眠相关疾病盛行率的持续上升，对可靠的正压治疗方案的需求预计将会增加，从而推动市场扩张，并巩固这些设备在医疗保健领域的重要性。

限制正压通气辅助装置市场的因素

正压通气辅助装置（PAP）在治疗睡眠呼吸障碍方面疗效显着，但许多患者面临阻碍其持续使用的挑战。面罩不适、配戴不合适、幽闭恐惧症等因素都会影响患者坚持治疗。此外，对PAP治疗长期健康益处的认知不足也会进一步阻碍患者继续使用。解决这些依从性问题对于充分发挥PAP装置的潜力并确保患者获得良好的治疗效果至关重要。因此，这项挑战对PAP装置市场的整体成长和成功有重大影响。

正压通气辅助装置市场趋势

正压通气（PAP）设备市场正呈现出显着的趋势，即整合远端监测和远端医疗解决方案。製造商正越来越多地将连接功能整合到设备中，使患者能够轻鬆地与医疗服务提供者共用治疗数据，从而实现即时回馈和个人化支援。这项进步提高了患者的治疗依从性，进而改善了整体治疗效果。随着医疗保健产业逐步采用数位化解决方案，预计这一趋势将进一步影响PAP设备市场，推动创新，并扩大睡眠呼吸中止症等疾病患者获得有效治疗的机会。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 专利分析
• 技术分析

全球正压通气（PAP）市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 持续性呼吸道正压通气（CPAP）
• 自动正压通气装置（APAP）
• 双水平正压通气（BiPAP）

全球正压通气（PAP）市场规模（按应用及复合年增长率划分）（2026-2033年）

• 阻塞型睡眠呼吸中止症症
• 呼吸衰竭
• 慢性阻塞性肺病（COPD）
• 其他的

全球正压通气（PAP）市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 居家医疗
• 睡眠检查室和诊所

全球正压通气（PAP）市场规模（按地区划分）及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• ResMed Inc.（USA）
• Koninklijke Philips NV（Netherlands）
• Fisher & Paykel Healthcare Corporation Limited（New Zealand）
• DeVilbiss Healthcare LLC（USA）
• Drive Medical（USA）
• 3B Medical, Inc.（USA）
• Apex Medical Corp.（Taiwan）
• BMC Medical Co., Ltd.（China）
• Somnetics International, Inc.（USA）
• Invacare Corporation（USA）
• Medtronic plc（Ireland）
• Vyaire Medical, Inc.（USA）
• Compumedics Limited（Australia）
• Lowenstein Medical Innovation GmbH & Co. KG（Germany）
• Teijin Pharma Limited（Japan）
• Nihon Kohden Corporation（Japan）
• Itamar Medical Ltd.（Israel）
• Circadiance LLC（USA）
• Breas Medical AB（Sweden）
• Weinmann Emergency Medical Technology GmbH+Co. KG（Germany）

结论与建议

Positive Airway Pressure Devices Market size was valued at USD 2.39 Billion in 2024 and is poised to grow from USD 2.51 Billion in 2025 to USD 3.77 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global market for Positive Airway Pressure (PAP) devices is experiencing significant growth, driven by heightened awareness and diagnosis of sleep-related breathing disorders like sleep apnea. These conditions greatly impact overall health, amplifying the demand for effective treatment options. PAP devices, particularly Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP), provide non-invasive solutions that enhance breathing and alleviate symptoms. Several factors fuel market expansion, including increasing healthcare spending, advancements in device technology for improved comfort and functionality, and a rising aging population susceptible to such disorders. Collaborations among manufacturers, healthcare providers, and research entities are fostering innovation. Nonetheless, challenges such as patient adherence, cost, and regulatory factors necessitate ongoing efforts in product refinement, distribution, and education to improve acceptance of PAP therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Positive Airway Pressure Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Positive Airway Pressure Devices Market Segments Analysis

Global Positive Airway Pressure Devices Market is segmented by Product Type, Application, End User and region. Based on Product Type, the market is segmented into Continuous Positive Airway Pressure (CPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices and Bi-level Positive Airway Pressure (BiPAP) Devices. Based on Application, the market is segmented into Obstructive Sleep Apnea, Respiratory Failures, Chronic Obstructive Pulmonary Disease (COPD) and Others. Based on End User, the market is segmented into Hospitals, Home Healthcare and Sleep Laboratories & Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Positive Airway Pressure Devices Market

The growth of the positive airway pressure devices market is significantly driven by the rising incidence of sleep disorders globally. Conditions such as obstructive sleep apnea require effective treatment solutions, and positive airway pressure devices are considered the standard in managing these issues. By facilitating unobstructed airflow during sleep, they play a vital role in addressing the complications associated with these disorders. As the prevalence of sleep-related ailments continues to rise, the demand for reliable PAP therapy solutions is anticipated to increase, thereby propelling market expansion and solidifying the importance of these devices in the healthcare landscape.

Restraints in the Positive Airway Pressure Devices Market

While Positive Airway Pressure (PAP) devices are highly effective in managing sleep-related breathing disorders, many individuals encounter challenges that hinder their consistent use. Factors such as discomfort from masks, poor fit, and feelings of claustrophobia can discourage adherence to prescribed therapy. Additionally, a lack of understanding of the long-term health benefits associated with PAP treatment may further diminish motivation among patients to maintain their usage. Addressing these non-adherence issues is essential for maximizing the potential of PAP devices and ensuring favorable outcomes for patients. Consequently, this challenge significantly impacts the overall growth and success of the PAP device market.

Market Trends of the Positive Airway Pressure Devices Market

The Positive Airway Pressure (PAP) devices market is witnessing a significant trend towards the integration of remote monitoring and telehealth solutions. Manufacturers are increasingly embedding connectivity features in their devices, enabling patients to share therapy data with healthcare providers easily, which allows for real-time feedback and personalized support. This advancement enhances patient adherence to treatment, improving overall management and outcomes. As the healthcare sector progressively embraces digital solutions, this trend is poised to further influence the PAP devices market, fostering innovation and expanding access to effective therapy for patients managing conditions like sleep apnea.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis
• Technology Analysis

Global Positive Airway Pressure Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Continuous Positive Airway Pressure (CPAP) Devices
• Automatic Positive Airway Pressure (APAP) Devices
• Bi-level Positive Airway Pressure (BiPAP) Devices

Global Positive Airway Pressure Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Obstructive Sleep Apnea
• Respiratory Failures
• Chronic Obstructive Pulmonary Disease (COPD)
• Others

Global Positive Airway Pressure Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Home Healthcare
• Sleep Laboratories & Clinics

Global Positive Airway Pressure Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare Corporation Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeVilbiss Healthcare LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3B Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apex Medical Corp. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMC Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Somnetics International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compumedics Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lowenstein Medical Innovation GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teijin Pharma Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Itamar Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Circadiance LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Breas Medical AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weinmann Emergency Medical Technology GmbH + Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations